PATENT CLAIM ANALYSIS

Application Number: 15861750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "307000"]

Abstract:
Derivatives of 1,2,3,4-tetrahydroisoquinoline (THIQ) having the general formula A-(CH 2 ) n —B are provided, wherein A is THIQ or a substituted derivative thereof and B is an aryl, cycloalkylaryl, or cycloalkyl group, wherein A and B are linked to each other by an alkyl or substituted alkyl chain. The compounds are useful as selective ligands (agonists or antagonists) of central nervous system receptors, and in particular of the seratonin receptors. The compounds or their salts can be formulated into pharmaceutical in need thereof by any route of administration suitable for a desired treatment protocol and especially for the treatment of psychiatric disorders.

Claim (Index 8):
A pharmaceutical composition comprising at least one of the compound of  claims 1 , and a pharmaceutically acceptable carrier, wherein the pharmaceutical composition is formulated to deliver an effective dose of the compound to a patient in need thereof

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.56
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11757246', '11628132', '12301180', '12643175', '12018172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7506130354249582
- 35 USC 102 Novelty (BERT): 0.4970680933313785
- Combined Prediction Score: 0.7252585412156002
- Mean Citation Score: 206.899168
- Max Citation Score: 208.25078
- Similarity Product: 134.8733204768419

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test